Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1173291
PUBLISHER: KBV Research | PRODUCT CODE: 1173291
LAMEA PEGylated Proteins Market Size, Share & Industry Trends Analysis Report By Product & Services, By Type, By End-user, By Application, By Country and Growth Forecast, 2022 - 2028
PUBLISHED:
PAGES: 96 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa PEGylated Proteins Market would witness market growth of 14.4% CAGR during the forecast period (2022-2028).
The pharmacological benefits and relevance of PEGylation of proteins also include greater drug stability, little loss of biological activity, decreased dosage frequency, and improved drug solubility. Cimzia, Macugen, Mircera, Somavert, Neulasta, and Pegasys are some of the pegylated medications that the FDA has approved. These medications are effective in the treatment of a wide range of conditions, including Crohn's disease, anemia in chronic renal disease, Acromegaly, age-related macular degeneration, hepatitis C, and neutropenia during chemotherapy.
PEG molecules are utilized in the conjugation of nanoparticles for anti-cancer medication delivery systems. By regulating the discharge of native protein from the conjugates into the circulation, the controlled releasable PEGs have been designed to prevent any loss of efficacy. The care of various chronic diseases, such as cancer, leukemia, rheumatoid arthritis, severe combined immunodeficiency disease, Crohn's disease, and hepatitis C, has been improved by the PEGylation of therapeutic proteins.
The most significant PEGylated medications are pegfilgrastim, pegaspargase, certolizumab pegol, pegademase bovine, pegvisomant, pegaptanib, and interferons. Determining clinically meaningful anti-PEG antibody titers is necessary to control the risk of adverse events following patient exposure to PEGylated medications since the formation of anti-PEG antibodies may decrease the efficacy and safety of PEGylated therapies.
The region's HIV epidemic is still predominantly concentrated in at-risk groups, with MSM and transgender women (TGW) bearing the brunt of the disease. The difficulties of late commencement and inadequate adherence to treatment continue. Regarding prevention, new research on PrEP willingness in important populations has yielded encouraging findings. At the same time, national health systems are increasingly adopting PrEP through implementation projects. Brazil's first year of offering PrEP in numerous cities across the entire nation provides a peek at real-world PrEP uptake.
The Brazil market dominated the LAMEA PEGylated Proteins Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $38.1 million by 2028.The Argentina market is exhibiting a CAGR of 15% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 14.1% during (2022 - 2028).
Based on Product & Services, the market is segmented into Consumables and Services. Based on Type, the market is segmented into Colony-stimulating Factor, Interferons, Recombinant Factor VII, Erythropoietin and Others. Based on End-user, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Academic & Research Institutes. Based on Application, the market is segmented into Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Millipore (Merck KGaA), Thermo Fisher Scientific, Inc., NOF Corporation, JenKem Technology Co. Ltd., Creative PEGworks, Celares GmbH, Quanta BioDesign, Ltd., Biomatrik, Inc., Iris Biotech GmbH, and Laysan Bio, Inc.
Scope of the Study
Market Segments covered in the Report:
By Product & Services
- Consumables
- Services
By Type
- Colony-stimulating Factor
- Interferons
- Recombinant Factor VII
- Erythropoietin
- Others
By End-user
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
By Application
- Cancer
- Autoimmune Diseases
- Hepatitis
- Multiple Sclerosis
- Hemophilia
- Gastrointestinal Disorders
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Merck Millipore (Merck KGaA)
- Thermo Fisher Scientific, Inc.
- NOF Corporation
- JenKem Technology Co. Ltd.
- Creative PEGworks
- Celares GmbH
- Quanta BioDesign, Ltd.
- Biomatrik, Inc.
- Iris Biotech GmbH
- Laysan Bio, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA PEGylated Proteins Market, by Product & Services
- 1.4.2 LAMEA PEGylated Proteins Market, by Type
- 1.4.3 LAMEA PEGylated Proteins Market, by End-user
- 1.4.4 LAMEA PEGylated Proteins Market, by Application
- 1.4.5 LAMEA PEGylated Proteins Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in PEGylated Proteins Market
Chapter 4. LAMEA PEGylated Proteins Market by Product & Services
- 4.1 LAMEA Consumables Market by Country
- 4.2 LAMEA Services Market by Country
Chapter 5. LAMEA PEGylated Proteins Market by Type
- 5.1 LAMEA Colony-stimulating Factor Market by Country
- 5.2 LAMEA Interferons Market by Country
- 5.3 LAMEA Recombinant Factor VII Market by Country
- 5.4 LAMEA Erythropoietin Market by Country
- 5.5 LAMEA Others Market by Country
Chapter 6. LAMEA PEGylated Proteins Market by End-user
- 6.1 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
- 6.2 LAMEA Contract Research Organizations (CROs) Market by Country
- 6.3 LAMEA Academic & Research Institutes Market by Country
Chapter 7. LAMEA PEGylated Proteins Market by Application
- 7.1 LAMEA Cancer Market by Country
- 7.2 LAMEA Autoimmune Diseases Market by Country
- 7.3 LAMEA Hepatitis Market by Country
- 7.4 LAMEA Multiple Sclerosis Market by Country
- 7.5 LAMEA Hemophilia Market by Country
- 7.6 LAMEA Gastrointestinal Disorders Market by Country
- 7.7 LAMEA Others Market by Country
Chapter 8. LAMEA PEGylated Proteins Market by Country
- 8.1 Brazil PEGylated Proteins Market
- 8.1.1 Brazil PEGylated Proteins Market by Product & Services
- 8.1.2 Brazil PEGylated Proteins Market by Type
- 8.1.3 Brazil PEGylated Proteins Market by End-user
- 8.1.4 Brazil PEGylated Proteins Market by Application
- 8.2 Argentina PEGylated Proteins Market
- 8.2.1 Argentina PEGylated Proteins Market by Product & Services
- 8.2.2 Argentina PEGylated Proteins Market by Type
- 8.2.3 Argentina PEGylated Proteins Market by End-user
- 8.2.4 Argentina PEGylated Proteins Market by Application
- 8.3 UAE PEGylated Proteins Market
- 8.3.1 UAE PEGylated Proteins Market by Product & Services
- 8.3.2 UAE PEGylated Proteins Market by Type
- 8.3.3 UAE PEGylated Proteins Market by End-user
- 8.3.4 UAE PEGylated Proteins Market by Application
- 8.4 Saudi Arabia PEGylated Proteins Market
- 8.4.1 Saudi Arabia PEGylated Proteins Market by Product & Services
- 8.4.2 Saudi Arabia PEGylated Proteins Market by Type
- 8.4.3 Saudi Arabia PEGylated Proteins Market by End-user
- 8.4.4 Saudi Arabia PEGylated Proteins Market by Application
- 8.5 South Africa PEGylated Proteins Market
- 8.5.1 South Africa PEGylated Proteins Market by Product & Services
- 8.5.2 South Africa PEGylated Proteins Market by Type
- 8.5.3 South Africa PEGylated Proteins Market by End-user
- 8.5.4 South Africa PEGylated Proteins Market by Application
- 8.6 Nigeria PEGylated Proteins Market
- 8.6.1 Nigeria PEGylated Proteins Market by Product & Services
- 8.6.2 Nigeria PEGylated Proteins Market by Type
- 8.6.3 Nigeria PEGylated Proteins Market by End-user
- 8.6.4 Nigeria PEGylated Proteins Market by Application
- 8.7 Rest of LAMEA PEGylated Proteins Market
- 8.7.1 Rest of LAMEA PEGylated Proteins Market by Product & Services
- 8.7.2 Rest of LAMEA PEGylated Proteins Market by Type
- 8.7.3 Rest of LAMEA PEGylated Proteins Market by End-user
- 8.7.4 Rest of LAMEA PEGylated Proteins Market by Application
Chapter 9. Company Profiles
- 9.1 Thermo Fisher Scientific, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Partnerships, Collaborations, and Agreements:
- 9.1.5.2 Product Launches and Product Expansions:
- 9.1.5.3 Acquisition and Mergers:
- 9.2 Merck Millipore ( Merck Group)
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.3 NOF Corporation
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.4 Beijing Jiankai Technology Co., Ltd. (Jenkem)
- 9.4.1 Company Overview
- 9.5 Creative PEGworks
- 9.5.1 Company Overview
- 9.6 Celares GmbH
- 9.6.1 Company Overview
- 9.7 Quanta BioDesign Ltd.
- 9.7.1 Company Overview
- 9.8 Biomatrik, Inc.
- 9.8.1 Company Overview
- 9.9 Iris Biotech GmbH
- 9.9.1 Company Overview
- 9.10. Laysan Bio, Inc.
- 9.10.1 Company Overview
LIST OF TABLES
- TABLE 1 LAMEA PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 2 LAMEA PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 3 LAMEA PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 4 LAMEA PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 5 LAMEA Consumables Market by Country, 2018 - 2021, USD Million
- TABLE 6 LAMEA Consumables Market by Country, 2022 - 2028, USD Million
- TABLE 7 LAMEA Services Market by Country, 2018 - 2021, USD Million
- TABLE 8 LAMEA Services Market by Country, 2022 - 2028, USD Million
- TABLE 9 LAMEA PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 10 LAMEA PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 11 LAMEA Colony-stimulating Factor Market by Country, 2018 - 2021, USD Million
- TABLE 12 LAMEA Colony-stimulating Factor Market by Country, 2022 - 2028, USD Million
- TABLE 13 LAMEA Interferons Market by Country, 2018 - 2021, USD Million
- TABLE 14 LAMEA Interferons Market by Country, 2022 - 2028, USD Million
- TABLE 15 LAMEA Recombinant Factor VII Market by Country, 2018 - 2021, USD Million
- TABLE 16 LAMEA Recombinant Factor VII Market by Country, 2022 - 2028, USD Million
- TABLE 17 LAMEA Erythropoietin Market by Country, 2018 - 2021, USD Million
- TABLE 18 LAMEA Erythropoietin Market by Country, 2022 - 2028, USD Million
- TABLE 19 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 20 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 21 LAMEA PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 22 LAMEA PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 23 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
- TABLE 24 LAMEA Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
- TABLE 25 LAMEA Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
- TABLE 26 LAMEA Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
- TABLE 27 LAMEA Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
- TABLE 28 LAMEA Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
- TABLE 29 LAMEA PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 30 LAMEA PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 31 LAMEA Cancer Market by Country, 2018 - 2021, USD Million
- TABLE 32 LAMEA Cancer Market by Country, 2022 - 2028, USD Million
- TABLE 33 LAMEA Autoimmune Diseases Market by Country, 2018 - 2021, USD Million
- TABLE 34 LAMEA Autoimmune Diseases Market by Country, 2022 - 2028, USD Million
- TABLE 35 LAMEA Hepatitis Market by Country, 2018 - 2021, USD Million
- TABLE 36 LAMEA Hepatitis Market by Country, 2022 - 2028, USD Million
- TABLE 37 LAMEA Multiple Sclerosis Market by Country, 2018 - 2021, USD Million
- TABLE 38 LAMEA Multiple Sclerosis Market by Country, 2022 - 2028, USD Million
- TABLE 39 LAMEA Hemophilia Market by Country, 2018 - 2021, USD Million
- TABLE 40 LAMEA Hemophilia Market by Country, 2022 - 2028, USD Million
- TABLE 41 LAMEA Gastrointestinal Disorders Market by Country, 2018 - 2021, USD Million
- TABLE 42 LAMEA Gastrointestinal Disorders Market by Country, 2022 - 2028, USD Million
- TABLE 43 LAMEA Others Market by Country, 2018 - 2021, USD Million
- TABLE 44 LAMEA Others Market by Country, 2022 - 2028, USD Million
- TABLE 45 LAMEA PEGylated Proteins Market by Country, 2018 - 2021, USD Million
- TABLE 46 LAMEA PEGylated Proteins Market by Country, 2022 - 2028, USD Million
- TABLE 47 Brazil PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 48 Brazil PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 49 Brazil PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 50 Brazil PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 51 Brazil PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 52 Brazil PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 53 Brazil PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 54 Brazil PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 55 Brazil PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 56 Brazil PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 57 Argentina PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 58 Argentina PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 59 Argentina PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 60 Argentina PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 61 Argentina PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 62 Argentina PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 63 Argentina PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 64 Argentina PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 65 Argentina PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 66 Argentina PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 67 UAE PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 68 UAE PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 69 UAE PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 70 UAE PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 71 UAE PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 72 UAE PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 73 UAE PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 74 UAE PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 75 UAE PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 76 UAE PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 77 Saudi Arabia PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 78 Saudi Arabia PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 79 Saudi Arabia PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 80 Saudi Arabia PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 81 Saudi Arabia PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 82 Saudi Arabia PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 83 Saudi Arabia PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 84 Saudi Arabia PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 85 Saudi Arabia PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 86 Saudi Arabia PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 87 South Africa PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 88 South Africa PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 89 South Africa PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 90 South Africa PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 91 South Africa PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 92 South Africa PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 93 South Africa PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 94 South Africa PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 95 South Africa PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 96 South Africa PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 97 Nigeria PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 98 Nigeria PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 99 Nigeria PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 100 Nigeria PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 101 Nigeria PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 102 Nigeria PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 103 Nigeria PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 104 Nigeria PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 105 Nigeria PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 106 Nigeria PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 107 Rest of LAMEA PEGylated Proteins Market, 2018 - 2021, USD Million
- TABLE 108 Rest of LAMEA PEGylated Proteins Market, 2022 - 2028, USD Million
- TABLE 109 Rest of LAMEA PEGylated Proteins Market by Product & Services, 2018 - 2021, USD Million
- TABLE 110 Rest of LAMEA PEGylated Proteins Market by Product & Services, 2022 - 2028, USD Million
- TABLE 111 Rest of LAMEA PEGylated Proteins Market by Type, 2018 - 2021, USD Million
- TABLE 112 Rest of LAMEA PEGylated Proteins Market by Type, 2022 - 2028, USD Million
- TABLE 113 Rest of LAMEA PEGylated Proteins Market by End-user, 2018 - 2021, USD Million
- TABLE 114 Rest of LAMEA PEGylated Proteins Market by End-user, 2022 - 2028, USD Million
- TABLE 115 Rest of LAMEA PEGylated Proteins Market by Application, 2018 - 2021, USD Million
- TABLE 116 Rest of LAMEA PEGylated Proteins Market by Application, 2022 - 2028, USD Million
- TABLE 117 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 118 Key Information - Merck Millipore
- TABLE 119 Key Information - nof corporation
- TABLE 120 Key Information - Beijing Jiankai Technology Co., Ltd.
- TABLE 121 Key Information - Creative PEGworks
- TABLE 122 Key Information - Celares gmbh
- TABLE 123 Key Information -Quanta biodesign ltd.
- TABLE 124 Key Information - biomatrik, inc.
- TABLE 125 Key Information - Iris biotech gmbh
- TABLE 126 Key Information - laysan bio, inc.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Recent strategies and developments: Thermo Fisher Scientific, Inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.